Macquarie Group
VIVO

Macquarie Group’s Meridian Bioscience Inc VIVO Stock Holding History

Macquarie Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-482
Closed -$15.6K – 2288
2022
Q2 		$15K Hold
482
– – ﹤0.01% 2386
2022
Q1 		$13 Hold
482
– – ﹤0.01% 2484
2021
Q4 		$10K Hold
482
– – ﹤0.01% 2519
2021
Q3 		$9K Hold
482
– – ﹤0.01% 2555
2021
Q2 		$11K Hold
482
– – ﹤0.01% 2464
2021
Q1 		$13K Sell
482
-228
-32% -$5.42K ﹤0.01% 2362
2020
Q4 		$13K Hold
710
– – ﹤0.01% 2280
2020
Q3 		$12K Hold
710
– – ﹤0.01% 2263
2020
Q2 		$17K Buy
+710
New +$10.3K ﹤0.01% 2214
2018
Q3 		– Sell
-7,476
Closed -$119K – 2320
2018
Q2 		$119K Buy
+7,476
New +$112K ﹤0.01% 1801

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group's VIVO Position: Q3 2022 in Review

Macquarie Group sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 482 shares — an estimated $15.6K sold.

Macquarie Group first reported a position in VIVO in Q2 2018 and held it in 10 quarters. The position peaked at $119K in Q2 2018. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Macquarie Group reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 482 Meridian Bioscience Inc shares in Q3 2022, an estimated $15.6K.
  • Macquarie Group first reported a position in Meridian Bioscience Inc in Q2 2018 and held it in 10 quarters.
  • Macquarie Group's Meridian Bioscience Inc position peaked at $119K in Q2 2018.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.